查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1942564

2026年全球循环性肿瘤细胞市场报告

Circulating Tumor Cells Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，循环性肿瘤细胞市场规模快速成长，预计将从2025年的132.7亿美元成长到2026年的149.9亿美元，复合年增长率达13.0%。过去几年的成长可归因于癌症发生率的上升、肿瘤学研究计画的扩展、血液诊断技术的日益普及、微创检测方法的广泛应用以及先进实验室技术的普及。

预计未来几年循环性肿瘤细胞）市场规模将快速成长，2030年将达到238.8亿美元，复合年增长率（CAGR）为12.3%。预测期内的成长将受到以下因素的驱动：个人化癌症诊断的日益普及、癌症生物标记研究投资的增加、自动化细胞捕获技术的广泛应用、对早期癌症检测工具的需求不断增长以及人工智慧在癌症诊断中日益增强的整合。预测期内的关键趋势包括：液态生物检体技术的日益广泛应用、微流体CTC分离装置的日益普及、自动化CTC分析系统的日益整合、肿瘤学研究应用的不断扩展以及对早期癌症检测的日益重视。

预计未来几年，癌症发生率的不断上升将推动循环性肿瘤细胞市场的扩张。癌症是一种体内某些细胞不受控制地生长并转移到其他器官和组织的疾病。循环性肿瘤细胞可用于癌症的早期检测和诊断，随着癌症发生率的持续上升，对这些技术的需求也随之增加。例如，根据世界卫生组织（世卫组织）2024年2月发布的数据，预计到2050年，新增癌症病例将超过3,500万例，比2022年估计的2,000万例增加77%。世卫组织是一个专注于全球卫生政策和公共卫生倡议的瑞士国际组织。因此，日益加重的癌症负担正在显着推动循环性肿瘤细胞市场的成长。

为了满足日益增长的对精准、非侵入性癌症诊断和更完善的个人化治疗监测的需求，循环性肿瘤细胞(CTC) 领域的主要企业正致力于开发先进的解决方案，例如生物标记特异性CTC 检测。这些生物标记特异性检测能够基于特定蛋白的表达来检测和详细表征循环性肿瘤细胞，从而提供比传统 CTC 计数技术（仅提供细胞总数）更丰富的表型资讯。例如，2023 年 7 月，总部位于义大利的诊断公司 Menarini Silicon Biosystems 在北美和欧洲推出了包含 DLL3 生物标记的 CELLSEARCH CTC 检测，目前仅供研究使用。此检测基于已获 FDA 批准的 CELLSEARCH 平台，旨在识别表达 DLL3 的循环性肿瘤细胞。 DLL3 是一种在侵袭性小细胞肺癌和神经内分泌肿瘤中过度表现的蛋白质。透过靶向 DLL3，该检测方法支持对预后不良相关的循环肿瘤细胞 (CTC) 进行表型分析，并促进以标靶治疗开发为重点的生物製药研究。这项进展使研究人员能够以非侵入性方式探索肿瘤异质性、追踪疾病进展并评估对精准疗法的反应。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球循环性肿瘤细胞市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 人工智慧与自主智能
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 物联网 (IoT)、智慧基础设施和互联生态系统
  • 主要趋势
    • 扩大液态生物检体技术的应用
    • 微流体肿瘤细胞分离装置的应用日益广泛
    • 自动化CTC分析系统整合方面的进展
    • 拓展肿瘤学研究应用
    • 人们越来越重视癌症早期检测

第五章 终端用户产业市场分析

  • 医院和癌症中心
  • 诊断检查室
  • 製药和生物技术公司
  • 学术研究机构
  • CRO（受託研究机构）

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球循环性肿瘤细胞市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球循环性肿瘤细胞市场规模、对比及成长率分析
  • 全球循环性肿瘤细胞市场表现：规模与成长，2020-2025年
  • 全球循环性肿瘤细胞市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场总量（TAM）

第九章 市场细分

  • 副产品
  • 试剂盒及试剂、采血管、装置或系统
  • 透过技术
  • CTC富集、CTC检测、CTC分析
  • 透过使用
  • 临床或液态生物检体，检查
  • 按类型细分：试剂盒和试剂
  • 细胞富集试剂盒、检测试剂盒、核酸分离试剂盒
  • 按类型细分：采血管
  • 标准采血管，特殊采血管
  • 按类型细分：设备或系统
  • 微流体装置、自动化细胞捕捉系统、影像系统

第十章 区域与国家分析

  • 全球循环性肿瘤细胞市场：区域表现及预测，2020-2025年、2025-2030年预测、2035年预测
  • 全球循环性肿瘤细胞市场：国家、市场表现及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 循环性肿瘤细胞市场：竞争格局及市场占有率（2024年）
  • 循环性肿瘤细胞市场：公司估值矩阵
  • 循环性肿瘤细胞市场：公司概况
    • BIOCEPT Inc.
    • Creativ MicroTech Inc.
    • Fluxion Biosciences Inc.
    • Ikonisys Inc.
    • ScreenCell SAS

第37章：其他领先和创新企业

  • Aviva Biosciences Corporation, LungLife AI Inc., Menarini Silicon Biosystems SpA, Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, Cynvenio Biosystems Inc., ApoCell Inc., Clearbridge BioMedics Pte. Ltd., Celsee Inc., RareCyte Inc., On-chip Biotechnologies Co. Ltd., Bio-Techne Corporation

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年循环性肿瘤细胞市场：提供新机会的国家
  • 2030年循环性肿瘤细胞市场：充满新机会的细分市场
  • 2030年循环性肿瘤细胞市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MCTCU01_G26Q1

Circulating tumor cells (CTCs) represent solid tumor-derived cells that have detached from the primary tumor and entered the bloodstream, providing valuable diagnostic and prognostic information for cancer.

The primary products related to circulating tumor cells encompass kits and reagents, along with blood collection tubes and devices or systems. Kits and reagents constitute a comprehensive set of consumables comprising elements such as a blood specimen separator, proprietary microfluidic capture chip, CTC enrichment, and immunostaining reagents. These products are utilized for collecting various specimens from the human body, including blood, bone marrow, and other bodily fluids. They leverage different technologies such as CTC enrichment, detection, and analysis, facilitating applications in clinical or liquid biopsy procedures, as well as in research endeavors.

Tariffs are impacting the circulating tumor cells market by increasing costs of imported microfluidic devices, imaging systems, reagents, and automated cell capture equipment. Oncology research centers and diagnostic laboratories in North America and Europe are most affected due to reliance on specialized imported instruments, while Asia-Pacific faces higher manufacturing input costs. These tariffs are raising test costs and slowing technology adoption. However, they are also encouraging domestic device development, localized reagent production, and regional innovation in liquid biopsy platforms.

The circulating tumor cells market research report is one of a series of new reports from The Business Research Company that provides circulating tumor cells market statistics, including circulating tumor cells industry global market size, regional shares, competitors with a circulating tumor cells market share, detailed circulating tumor cells market segments, market trends and opportunities, and any further data you may need to thrive in the circulating tumor cells industry. This circulating tumor cells market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The circulating tumor cells market size has grown rapidly in recent years. It will grow from $13.27 billion in 2025 to $14.99 billion in 2026 at a compound annual growth rate (CAGR) of 13.0%. The growth in the historic period can be attributed to increasing cancer incidence rates, expansion of oncology research programs, growing use of blood-based diagnostics, rising adoption of minimally invasive testing methods, availability of advanced laboratory technologies.

The circulating tumor cells market size is expected to see rapid growth in the next few years. It will grow to $23.88 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to increasing adoption of personalized oncology diagnostics, rising investments in cancer biomarker research, expansion of automated cell capture technologies, growing demand for early-stage cancer detection tools, increasing integration of ai in oncology diagnostics. Major trends in the forecast period include increasing use of liquid biopsy techniques, rising adoption of microfluidic ctc isolation devices, growing integration of automated ctc analysis systems, expansion of oncology research applications, enhanced focus on early cancer detection.

The increasing prevalence of cancer is anticipated to drive the expansion of the circulating tumor cells market in the coming years. Cancer is a condition in which certain cells in the body multiply uncontrollably and spread to other organs or tissues. Circulating tumor cells are utilized for the early identification and diagnosis of cancer, and as cancer incidence continues to rise, the demand for these technologies is growing accordingly. For example, in February 2024, according to the World Health Organization, a Switzerland-based international body focused on global health policy and public health initiatives, more than 35 million new cancer cases are projected by 2050, representing a 77% increase compared with the estimated 20 million cases reported in 2022. As a result, the rising burden of cancer is contributing significantly to the growth of the circulating tumor cells market.

Leading companies operating in the circulating tumor cells (CTC) space are increasingly concentrating on the development of advanced solutions, such as biomarker-specific CTC assays, to address the growing need for accurate, non-invasive cancer diagnostics and improved personalized treatment monitoring. These biomarker-specific assays allow for the detection and detailed characterization of circulating tumor cells based on particular protein expressions, providing richer phenotypic insights than conventional CTC enumeration techniques that largely deliver only total cell counts. For instance, in July 2023, Menarini Silicon Biosystems S.p.A., an Italy-based diagnostics firm, launched the CELLSEARCH CTC test incorporating the DLL3 biomarker as a Research Use Only service across North America and Europe. Built on the FDA-cleared CELLSEARCH platform, the assay is designed to identify circulating tumor cells expressing DLL3, a protein commonly overexpressed in aggressive small-cell lung cancer and neuroendocrine tumors. By targeting DLL3, the test supports phenotypic profiling of CTCs linked to poor prognosis, thereby aiding biopharmaceutical research focused on targeted therapy development. This advancement offers researchers a non-invasive approach to investigate tumor heterogeneity, track disease progression, and assess responses to precision treatments.

In August 2023, Cell Microsystems, a US-based biotechnology company, acquired Fluxion Biosciences for an undisclosed amount. This acquisition is intended to strengthen Cell Microsystems' capabilities in cell analysis and offer advanced solutions for both research and clinical applications. Fluxion Biosciences, also based in the US, specializes in technologies for isolating and analyzing circulating tumor cells (CTCs).

Major companies operating in the circulating tumor cells market are BIOCEPT Inc., Creativ MicroTech Inc., Fluxion Biosciences Inc., Ikonisys Inc., ScreenCell SAS, Aviva Biosciences Corporation, LungLife AI Inc., Menarini Silicon Biosystems S.p.A., Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, Cynvenio Biosystems Inc., ApoCell Inc., Clearbridge BioMedics Pte. Ltd., Celsee Inc., RareCyte Inc., On-chip Biotechnologies Co. Ltd., Bio-Techne Corporation, Qiagen N.V., STEMCELL Technologies Inc., Sysmex Corporation, Miltenyi Biotec GmbH, Thermo Fisher Scientific Inc., Greiner Bio-One International GmbH, Agilent Technologies Inc.

North America was the largest region in the circulating tumor cells market in 2025. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the circulating tumor cells market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The circulating tumor cells market consists of sales of clinical samples, KRT7, PSMA positive cells, and TTF-1 positive. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Circulating Tumor Cells Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses circulating tumor cells market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for circulating tumor cells ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The circulating tumor cells market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Kits And Reagents; Blood Collection Tubes; Devices Or Systems
  • 2) By Technology: CTC Enrichment; CTC Detection; CTC Analysis
  • 3) By Application: Clinical Or Liquid Biopsy; Research
  • Subsegments:
  • 1) By Kits And Reagents: Cell Enrichment Kits; Detection Kits; Nucleic Acid Isolation Kits
  • 2) By Blood Collection Tubes: Standard Blood Collection Tubes; Specialized Blood Collection Tubes
  • 3) By Devices Or Systems: Microfluidic Devices; Automated Cell Capture Systems; Imaging Systems
  • Companies Mentioned: BIOCEPT Inc.; Creativ MicroTech Inc.; Fluxion Biosciences Inc.; Ikonisys Inc.; ScreenCell SAS; Aviva Biosciences Corporation; LungLife AI Inc.; Menarini Silicon Biosystems S.p.A.; Canopus Bioscience Ltd.; IVDiagnostics Inc.; BioFluidica Inc.; Biolidics Limited; Rarecells Diagnostics SAS; Cynvenio Biosystems Inc.; ApoCell Inc.; Clearbridge BioMedics Pte. Ltd.; Celsee Inc.; RareCyte Inc.; On-chip Biotechnologies Co. Ltd.; Bio-Techne Corporation; Qiagen N.V.; STEMCELL Technologies Inc.; Sysmex Corporation; Miltenyi Biotec GmbH; Thermo Fisher Scientific Inc.; Greiner Bio-One International GmbH; Agilent Technologies Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Circulating Tumor Cells Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Circulating Tumor Cells Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Circulating Tumor Cells Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Circulating Tumor Cells Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics And Precision Medicine
    • 4.1.2 Artificial Intelligence And Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data And Cybersecurity
    • 4.1.4 Industry 4.0 And Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure And Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Use Of Liquid Biopsy Techniques
    • 4.2.2 Rising Adoption Of Microfluidic Ctc Isolation Devices
    • 4.2.3 Growing Integration Of Automated Ctc Analysis Systems
    • 4.2.4 Expansion Of Oncology Research Applications
    • 4.2.5 Enhanced Focus On Early Cancer Detection

5. Circulating Tumor Cells Market Analysis Of End Use Industries

  • 5.1 Hospitals And Cancer Centers
  • 5.2 Diagnostic Laboratories
  • 5.3 Pharmaceutical And Biotechnology Companies
  • 5.4 Academic And Research Institutes
  • 5.5 Contract Research Organizations

6. Circulating Tumor Cells Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Circulating Tumor Cells Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Circulating Tumor Cells PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Circulating Tumor Cells Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Circulating Tumor Cells Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Circulating Tumor Cells Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Circulating Tumor Cells Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Circulating Tumor Cells Market Segmentation

  • 9.1. Global Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Kits And Reagents, Blood Collection Tubes, Devices Or Systems
  • 9.2. Global Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • CTC Enrichment, CTC Detection, CTC Analysis
  • 9.3. Global Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Clinical Or Liquid Biopsy, Research
  • 9.4. Global Circulating Tumor Cells Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cell Enrichment Kits, Detection Kits, Nucleic Acid Isolation Kits
  • 9.5. Global Circulating Tumor Cells Market, Sub-Segmentation Of Blood Collection Tubes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Standard Blood Collection Tubes, Specialized Blood Collection Tubes
  • 9.6. Global Circulating Tumor Cells Market, Sub-Segmentation Of Devices Or Systems, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Microfluidic Devices, Automated Cell Capture Systems, Imaging Systems

10. Circulating Tumor Cells Market Regional And Country Analysis

  • 10.1. Global Circulating Tumor Cells Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Circulating Tumor Cells Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Circulating Tumor Cells Market

  • 11.1. Asia-Pacific Circulating Tumor Cells Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Circulating Tumor Cells Market

  • 12.1. China Circulating Tumor Cells Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Circulating Tumor Cells Market

  • 13.1. India Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Circulating Tumor Cells Market

  • 14.1. Japan Circulating Tumor Cells Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Circulating Tumor Cells Market

  • 15.1. Australia Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Circulating Tumor Cells Market

  • 16.1. Indonesia Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Circulating Tumor Cells Market

  • 17.1. South Korea Circulating Tumor Cells Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Circulating Tumor Cells Market

  • 18.1. Taiwan Circulating Tumor Cells Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Circulating Tumor Cells Market

  • 19.1. South East Asia Circulating Tumor Cells Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Circulating Tumor Cells Market

  • 20.1. Western Europe Circulating Tumor Cells Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Circulating Tumor Cells Market

  • 21.1. UK Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Circulating Tumor Cells Market

  • 22.1. Germany Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Circulating Tumor Cells Market

  • 23.1. France Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Circulating Tumor Cells Market

  • 24.1. Italy Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Circulating Tumor Cells Market

  • 25.1. Spain Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Circulating Tumor Cells Market

  • 26.1. Eastern Europe Circulating Tumor Cells Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Circulating Tumor Cells Market

  • 27.1. Russia Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Circulating Tumor Cells Market

  • 28.1. North America Circulating Tumor Cells Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Circulating Tumor Cells Market

  • 29.1. USA Circulating Tumor Cells Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Circulating Tumor Cells Market

  • 30.1. Canada Circulating Tumor Cells Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Circulating Tumor Cells Market

  • 31.1. South America Circulating Tumor Cells Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Circulating Tumor Cells Market

  • 32.1. Brazil Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Circulating Tumor Cells Market

  • 33.1. Middle East Circulating Tumor Cells Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Circulating Tumor Cells Market

  • 34.1. Africa Circulating Tumor Cells Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Circulating Tumor Cells Market Regulatory and Investment Landscape

36. Circulating Tumor Cells Market Competitive Landscape And Company Profiles

  • 36.1. Circulating Tumor Cells Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Circulating Tumor Cells Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Circulating Tumor Cells Market Company Profiles
    • 36.3.1. BIOCEPT Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Creativ MicroTech Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Fluxion Biosciences Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Ikonisys Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. ScreenCell SAS Overview, Products and Services, Strategy and Financial Analysis

37. Circulating Tumor Cells Market Other Major And Innovative Companies

  • Aviva Biosciences Corporation, LungLife AI Inc., Menarini Silicon Biosystems S.p.A., Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, Cynvenio Biosystems Inc., ApoCell Inc., Clearbridge BioMedics Pte. Ltd., Celsee Inc., RareCyte Inc., On-chip Biotechnologies Co. Ltd., Bio-Techne Corporation

38. Global Circulating Tumor Cells Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Circulating Tumor Cells Market

40. Circulating Tumor Cells Market High Potential Countries, Segments and Strategies

  • 40.1 Circulating Tumor Cells Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Circulating Tumor Cells Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Circulating Tumor Cells Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer